Enanta Pharmaceuticals, Inc. (ENTA)
12.51
-0.49
(-3.77%)
USD |
NASDAQ |
Mar 20, 16:00
12.54
+0.03
(+0.24%)
Pre-Market: 20:00
Enanta Pharmaceuticals Research and Development Expense (Quarterly) : 20.86M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Agios Pharmaceuticals, Inc. | 86.79M |
| ACADIA Pharmaceuticals, Inc. | 84.76M |
| Alnylam Pharmaceuticals, Inc. | 372.22M |
| Savara, Inc. | 20.90M |
| BioMarin Pharmaceutical, Inc. | 192.41M |